LICART FDA approval date

The FDA approved LICART on 19 Dec 2018.

FDA approval date
19 Dec 2018

Drug identity has not yet been verified against registry records

Also recorded as DICLOFENAC EPOLAMINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-12-19DayLICARTFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206976", "applicant_as_listed_by_fda": "IBSA INST BIO", "brand_names": ["LICART"], "active_ingredients": ["DICLOFENAC EPOLAMINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20181219", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026